Skip to main content
logo
Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
3.880
+0.150 (4.02%)
Aug 10, 2026, 12:03 PM EDT - Market open

Pyxis Oncology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
24672948147353
Market Cap Growth
277.92%-22.93%16.13%71.97%-86.75%-
Enterprise Value
223.0623.91-13.18-17.41-113.5378.92
Last Close Price
3.881.151.561.801.3410.97

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
17.285.205.79---
PB Ratio
7.501.350.770.640.291.35
P/TBV Ratio
7.791.340.770.710.280.36

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
15.641.73-0.82---
EV/EBITDA Ratio
--0.150.220.92-
EV/EBIT Ratio
--0.150.210.92-
EV/FCF Ratio
--0.230.221.19-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.530.320.160.160.120
Net Debt / Equity Ratio
-0.73-0.90-0.88-0.78-1.00-1.05
Net Debt / EBITDA Ratio
0.280.601.231.221.313.98
Net Debt / FCF Ratio
0.340.761.841.261.687.66
Asset Turnover
0.180.110.10000
Quick Ratio
2.483.167.184.635.6714.69
Current Ratio
2.763.417.494.845.9014.90
Return on Equity (ROE)
-135.48%-88.25%-66.27%-51.51%-55.88%-56.42%
Return on Assets (ROA)
-110.76%-66.69%-55.54%-42.69%-50.26%-48.05%
Return on Invested Capital (ROIC)
-1256.89%-861.82%-440.14%-583.18%--
Return on Capital Employed (ROCE)
-145.34%-80.44%-62.24%-50.16%-55.99%-52.07%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-3.06%-6.33%-46.46%-20.80%-288.93%-724.14%
Total Shareholder Return
-3.06%-6.33%-46.46%-20.80%-288.93%-724.14%
SEC Filings: 10-K · 10-Q